Effetti della zonisamide sull'EEG: Uno studio quantitativo ed ispettivo in pazienti epilettici

Translated title of the contribution: Effects of zonisamide on EEG: A quantitative and inspective study in patients with epilepsy

P. Pulitano, J. Fattouch, P. Li Voti, M. Falla, A. Zarabla, O. Mecarelli, A. T. Giallonardo

Research output: Contribution to journalArticlepeer-review

Abstract

Zonisamide (ZNS) is effective and well tolerated when used as adjunctive therapy in the treatment of partial epilepsies. The aim of our study is to evaluate the effect of ZNS on background activity organisation and preexisting abnormalities in patients with epilepsy. We studied 15 patients (mean age 39.4 ± 16.8 aa) treated with ZNS in add-on (daily dose: 350 ± 51 mg) for 12-54 weeks (average: 31 ± 17 weeks). Inspective analysis showed that most of EEG recordings were unchanged. Quantitative analysis showed a slight increment of delta-theta activity compared to the baseline, Our preliminary study suggests that, in general, ZNS has good neurophysiologic tolerability in epileptic patients.

Translated title of the contributionEffects of zonisamide on EEG: A quantitative and inspective study in patients with epilepsy
Original languageItalian
Pages (from-to)253-254
Number of pages2
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number136-137
Publication statusPublished - May 2008

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Effects of zonisamide on EEG: A quantitative and inspective study in patients with epilepsy'. Together they form a unique fingerprint.

Cite this